Resveratrol: challenges in analyzing its biological effects (Q38969879)

8 September 2017

Resveratrol: challenges in analyzing its biological effects (English)

1 reference

8 September 2017

1

1 reference

PubMed ID

26315294

8 September 2017

language of work or name

English

0 references

publication date

1 August 2015

1 reference

Annals of the New York Academy of Sciences

8 September 2017

1 reference

8 September 2017

1348

1 reference

8 September 2017

161-170

1 reference

8 September 2017

1

1 reference

Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography

8 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Identification of carbonyl reductase 1 as a resveratrol-binding protein by affinity chromatography using 4'-amino-3,5-dihydroxy-trans-stilbene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Integrin alphaVbeta3 contains a receptor site for resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Stroke risk and NSAIDs: a systematic review of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

The pleiotropic functions of aspirin: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

The ancient drug salicylate directly activates AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

AMPK: a target for drugs and natural products with effects on both diabetes and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Anti-inflammatory effects of aspirin and sodium salicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Modulation of adipose tissue inflammation by bioactive food compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Potent inhibitory action of red wine polyphenols on human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Inhibition of human lung cancer cell proliferation and survival by wine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Cytotoxic, cytoprotective and antioxidant activities of resveratrol and analogues in C6 astroglioma cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Resveratrol arrests the cell division cycle at S/G2 phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Induction of a reversible, non-cytotoxic S-phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Resveratrol regulates p66Shc activation in HaCaT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Sichuan pepper extracts block the PAK1/cyclin D1 pathway and the growth of NF1-deficient cancer xenograft in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Absorption of three wine-related polyphenols in three different matrices by healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

High absorption but very low bioavailability of oral resveratrol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Pharmacokinetics of resveratrol metabolic profile in healthy humans after moderate consumption of red wine and grape extract tablets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Bioavailability of trans-resveratrol from red wine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides - two novel resveratrol metabolites in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Distribution of [3H]trans-resveratrol in rat tissues following oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Development and evaluation of emulsion-liposome blends for resveratrol delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Interaction of transresveratrol with plasma lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

A characterization study of resveratrol/sulfobutyl ether-β-cyclodextrin inclusion complex and in vitro anticancer activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Development of a lozenge for oral transmucosal delivery of trans-resveratrol in humans: proof of concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Resveratrol supplementation: Where are we now and where should we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Pharmacokinetic Study oftrans-Resveratrol in Adult Pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

Development of a Rapid LC-UV Method for the Investigation of Chemical and Metabolic Stability of Resveratrol Oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12879

21 January 2018

Identifiers

DOI

10.1111/NYAS.12879

1 reference

8 September 2017

1 reference

PubMed ID

26315294